Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
The American Journal of Managed Care
|
December 26, 2002
Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective
Gregory de Lissovoy, Prasun Subedi
The American Journal of Managed Care
|
September 16, 2005
Treatment of overactive bladder: a model comparing extended-release formulations of tolterodine and oxybutynin
Eleanor M Perfetto, Prasun Subedi, Zhanna Jumadilova
Journal of Managed Care Pharmacy : JMCP
|
November 15, 2011
Something old, something new, something borrowed...comparative effectiveness research: a policy perspective
Prasun Subedi, Eleanor M Perfetto, Riaz Ali
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 8, 2016
Financing a Cure for Diabetes in a Multipayer Environment
Anirban Basu, Prasun Subedi, Sachin Kamal-Bahl
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Economic burden of uncomplicated urinary tract infections: direct, indirect and intangible costs
Karen N Keating, Eleanor M Perfetto, Prasun Subedi
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Economic and patient-reported outcomes of oral triptans in the treatment of migraine
Eleanor M Perfetto, Prasun Subedi, Paul J Healey, et al.
BMC Medical Research Methodology
|
December 14, 2012
From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer
Richard J Willke, Zhiyuan Zheng, Prasun Subedi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 18, 2015
Optimizing the leveraging of real-world data to improve the development and use of medicines
Marc L Berger, Craig Lipset, Alex Gutteridge, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 15, 2005
An economic evaluation of triptan products for migraine
Eleanor M Perfetto, Kathleen A Weis, C Daniel Mullins, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
July 25, 2018
A cost-benefit analysis of smoking cessation prescription coverage from a US payer perspective
Christine L Baker, Yao Ding, Cheryl P Ferrufino, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
The American Journal of Managed Care
|
December 26, 2002
Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective
Gregory de Lissovoy, Prasun Subedi
The American Journal of Managed Care
|
September 16, 2005
Treatment of overactive bladder: a model comparing extended-release formulations of tolterodine and oxybutynin
Eleanor M Perfetto, Prasun Subedi, Zhanna Jumadilova
Journal of Managed Care Pharmacy : JMCP
|
November 15, 2011
Something old, something new, something borrowed...comparative effectiveness research: a policy perspective
Prasun Subedi, Eleanor M Perfetto, Riaz Ali
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 8, 2016
Financing a Cure for Diabetes in a Multipayer Environment
Anirban Basu, Prasun Subedi, Sachin Kamal-Bahl
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Economic burden of uncomplicated urinary tract infections: direct, indirect and intangible costs
Karen N Keating, Eleanor M Perfetto, Prasun Subedi
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Economic and patient-reported outcomes of oral triptans in the treatment of migraine
Eleanor M Perfetto, Prasun Subedi, Paul J Healey, et al.
BMC Medical Research Methodology
|
December 14, 2012
From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer
Richard J Willke, Zhiyuan Zheng, Prasun Subedi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 18, 2015
Optimizing the leveraging of real-world data to improve the development and use of medicines
Marc L Berger, Craig Lipset, Alex Gutteridge, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 15, 2005
An economic evaluation of triptan products for migraine
Eleanor M Perfetto, Kathleen A Weis, C Daniel Mullins, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
July 25, 2018
A cost-benefit analysis of smoking cessation prescription coverage from a US payer perspective
Christine L Baker, Yao Ding, Cheryl P Ferrufino, et al.
Page
of 2